Prebiotic supplementation in patients with type 1 diabetes: study protocol for a randomised controlled trial in Canada
Introduction Type 1 diabetes (T1D) mellitus is caused by autoimmune destruction of insulin-producing beta-cells, requiring exogenous insulin to sustain life. Achieving near normal blood glucose levels with insulin, a primary goal of diabetes management, carries a significant risk of hypoglycaemia. T...
Saved in:
| Main Authors: | Shyamchand Mayengbam, Raylene A Reimer, Sonia Butalia, Carol Huang, Elizabeth Rosolowsky, Munier A Nour, Josephine Ho, Weilan Wang, Shannon Pyke, Heidi Virtanen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-05-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/5/e102486.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Skeletal Muscle Composition and the Effects of Exercise and/or Prebiotic Fiber in Preventing Diet Related Morbidities
by: Heiliane de Brito Fontana, et al.
Published: (2025-03-01) -
Effects of autochthonous bacteria and prebiotic supplementation on the growth and survival of Clarias batrachus
by: T. Rahman
Published: (2020-12-01) -
Prebiotic fiber enteral supplementation after allogeneic transplantation: feasibility and impact on the microbiome
by: Sarah Andersen, et al.
Published: (2025-08-01) -
Prebiotics and Probiotics Supplementation in Pigs as a Model for Human Gut Health and Disease
by: Raffaella Rossi, et al.
Published: (2025-05-01) -
Prebiotics Do Not Influence the Severity of Atopic Dermatitis in Infants: A Randomised Controlled Trial.
by: Jan Boženský, et al.
Published: (2015-01-01)